Table 2 Comparison of patient characteristics with or without the infectious postoperative complications after transthoracic esophagectomy

Sex

Male / Female

17/7

10/2

7/5

0.3707

Age

Mean ± SD

68.1 ± 7.7

70.5 ± 8.8

65.8 ± 6.4

0.1698

Height (cm)

Mean ± SD

161.9 ± 9.1

163.0 ± 8.6

160.8 ± 10.3

0.7439

Preoperative BW (kg)

Mean ± SD

56.5 ± 12.5

55.1 ± 13.6

58.0 ± 11.8

0.4010

BMI (kg/m²)

Mean ± SD

21.3 ± 3.4

20.6 ± 4.0

22.0 ± 2.7

0.4862

Preoperative therapy

none

5

3

2

1.0000

Chemo/CRT

14/5

6/3

8/2

ASA-PS

<=1 / > = 2

7/17

4/8

3/9

1.0000

PNI (Onodera et al.)

Mean ± SD

44.6 ± 5.7

44.5 ± 6.0

44.8 ± 5.8

0.9323

Reconstruction route

ITH / PMD / RST

10/10/4

6/5/1

4/5/3

0.6634

Lymph node dissection

<=2 / 3fields

12/12

7/5

5/7

0.6843

Operative time (min)

Mean ± SD

403.3 ± 54.7

394.8 ± 46.6

411.8 ± 64.8

0.3259

Intraoperative Blood Loss (mL)

Mean ± SD

513.3 ± 271.4

520.4 ± 285.9

506.3 ± 268.6

0.9081

RBC transfusion intraoperative early postope, ~2POD

No/Yes

23/1

11/1

12/0

1.0000

No/Yes

17/7

8/4

9/3

1.0000

Steroid use (~7POD)

No/Yes

17/7

7/5

10/2

0.3707

Sivelestat use (~7POD)

No/Yes

16/8

6/6

10/2

0.1930

Resection

R0,1/R2

20/4

11/1

9/3

0.5901

pT

0/1a/1b/2

1/2/2/4

1/1/0/1

0/1/2/3

0.4003

3/4

12/3

8/1

4/2

pN

0

4

2

2

1.0000

1/2/3

14/2/4

6/2/2

8/0/2

pM^a

0 / 1

23/1

12 / 0

11 / 1

1.0000